Biogen Inc. (NASDAQ:BIIB) is one of the best S&P 500 stocks with huge upside potential. As of June 16, Biogen emerged as a ...

The company’s unique campaign for a rare, terminal illness nabbed millions of views and a spot on the main stage at the ...

As the saying goes, “If you don’t laugh, you’ll cry.” Biogen and ad agency 21Grams took that mantra to heart with their Gold ...

With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...

Biogen's "Friedreich's Back" Takes Top Honors in Pharma; 21GRAMS Named No. 2 Healthcare Agency and Real Chemistry Ranked No. 2 Healthcare Network Globally on Creative Community's Biggest Stage Real ...

Friedreich's Ataxia Market Report Metrics . Details . Study Period. 2020–2034. Coverage. 7MM [The United States, the EU4 (Germany, France, Italy, and Spain) and The United Kingdom, and Japan].

In this video David Lynch, MD, PhD, discusses current treatment options for Friedreich's ataxia patients.

Beim Zerbrechen zerbröselt der Nikolaus in 1000 Stücke. Die Schokolade schmilzt, sobald man sie zwischen den Fingern hält. Der Profi ist skeptisch.

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the process of definitive diagnosis through genetic testing, and the ...

Friedreich ataxia (FA) is a rare inherited disease that affects the nervous system. It is usually diagnosed in childhood and affects about 5,000 people in the U.S. It causes a loss of muscle control.